Artemisinin derivative against severe malaria. Artemotil registration according to European standards;Artemotil geregistreerd volgens Europese normen: Artemisininederivaat tegen ernstige malaria

Pharmaceutisch Weekblad

Volumn 135, Issue 31, 2000, Pages 1156-1160

  Lugt, C B ^a   Oosterhuis, B ^a   Peeters, P A M ^a  

^a ARTECEF BV   (Netherlands)

Author keywords

Artemisinin; Artemotil; Drug approval; Injections, intramuscular; Malaria

Indexed keywords

ARTEETHER; ARTEMISININ; UNCLASSIFIED DRUG;

ARTICLE; DRUG APPROVAL; HUMAN; MALARIA; NETHERLANDS; PLASMODIUM FALCIPARUM;

EID: 0034604679     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Drug resistance in malaria
2. Qinghaosu (artemisinin): An antimalarial drug from China
3. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria
4. Een nieuwe therapie voor malaria. Artemisininederivaten: Geen bijwerkingen, geen resistentie
5. Role of arteether in the treatment of malaria and plans for further development
6. De behandeling van malaria
7. CNS adverse events associated with antimalarial agents. Fact or fiction?
8. Neurotoxicity and artemisinin compounds: Do the observations in animals justify limitation of clinical use?
9. A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria